维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="Hart LL"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE study 显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
2	Ma-trix metalloproteinase and tissue inhibitor of matrix met-alloproteinase mRNA levels are specifically altered in tornrotator cuff tendons显示文摘	Lo IK Marchuk LL Hollinshead R Hart DA	2004	Am J Sports Med2004，32，5：	1
3	Metastatic hemangiopericytoma with prolonged survival显示文摘	Weinberg JB	1987	Cancer1987，60，：	1
4	Analysis of potential predictive markers of cetuximab benefit in BMS099,a phase Ⅲ study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer显示文摘	Khambata-Ford S Harbison CT Hart LL		0，，06：	1
5	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastat- ic colorectal cancer: results of the TREE study显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin On- col2008，26，21：	1
6	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE Study显示文摘	Hochster HS Hart LL Ramanathan RK		0，，21：	1
7	Analysis of potential predictive markers of cetuximab benefit in BMS099,a phase Ⅲ study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer显示文摘	Khambata-Ford S Harbison CT Hart LL	2010	J Clin Oncol2010，28，6：	1
8	Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC) : Final analysis of the TREE-Study 显示文摘	Hochster HS Hart LL Ramanathan RK	2006	Proc Am Soc Clin Oncol2006，24，18：	1
9	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE Study显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
10	Using real time RT-PCR analysis to determine multiple gene expression patterns during XX and XY mouse fetal gonad development 显示文摘	Bouma GJ Hart GT Washburn LL	2004	Gene Expr Patterns2004，5，：	1
11	Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer( mCRC ) : Final analysis of the TREE-Study ( abstract3510 ) 显示文摘	Hochster HS Hart LL Ramanathan RK	2006	J Clin Oncol2006，24，18：	1
12	Randomized phase Ⅱ trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer显示文摘	Socinski MA Weissman C Hart LL	2006	J Clin Oncol2006，24，30：	1
13	K-Ras mutations (MT) and EGFR-related markers as potential predictors of cetuximab benefit in 1 st line advanced NSCLC:Results from the BMS099 study显示文摘	Khambata-Ford S Harbison CT Hart LL	2008	J Thorac Oncol2008，，：	1
14	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study显示文摘	Hoehster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
15	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study 显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
16	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE Study显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，13，21：	1
17	Analysis of potential predictive markers of cetuximab benefit in BMS099,a phase Ⅲ study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer显示文摘	Khambata-Ford S Harbison CT Hart LL	2010	J Clin Oncol2010，28，6：	1
18	Safety and effi- cacy of oxaliplatin and fluoropyrimidine regimens with or with- out bevacizumab as first-line treatment of metastatic colorectal cancer: resuhs of the TREE study 显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
19	Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): Final analysis of the TREE Study显示文摘	Hochster HS Hart LL Ramanathan RK	2006	J Clin Oncol2006，24，21：	1
20	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE study显示文摘	Hochster HS Hart LL Ramanathan RK		Journal of Clinical Oncology0，，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示